Cogent Biosciences (COGT) Prepaid Assets (2017 - 2026)
Cogent Biosciences (COGT) posted quarterly Prepaid Assets of $11.4 million for Q1 2026, up 58.18% year-over-year from $7.2 million in Q1 2025, and up 19.13% quarter-over-quarter from $9.6 million in Q4 2025.
Cogent Biosciences (COGT) Prepaid Assets (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Prepaid Assets for 10 consecutive years, with $11.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 58.18% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (up 58.18% YoY), while the FY2025 annual figure was $9.6 million, up 2.08% from the prior year.
- Prepaid Assets rose to $11.4 million in Q1 2026 per COGT's latest filing, from $9.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $11.4 million in Q1 2026 and bottomed at $3.7 million in Q1 2022.
- Historically, Prepaid Assets has averaged $6.5 million across 5 years, with a median of $6.2 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 177.14% — and 2024, when it declined 13.06%.
- Cogent Biosciences' Prepaid Assets stood at $4.4 million in 2022, then increased by 14.11% to $5.1 million in 2023, then jumped by 85.64% to $9.4 million in 2024, then grew by 2.08% to $9.6 million in 2025, then climbed by 19.13% to $11.4 million in 2026.
- Business Quant data shows COGT's Prepaid Assets at $11.4 million in Q1 2026, $9.6 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Mn |
| Mar 31, 2026 | 11.43 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | 7.16 Mn |
| Mar 31, 2025 | 7.22 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 6.76 Mn |
| Mar 31, 2024 | 6.16 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | 6.91 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | 6.07 Mn |
| Jun 30, 2022 | 3.86 Mn |
| Mar 31, 2022 | 3.69 Mn |
| Dec 31, 2021 | 2.95 Mn |
| Sep 30, 2021 | 4.62 Mn |